Study to evaluate the safety and efficacy of Phenyramidol Tablet in the treatment of Patients suffering from acute conditions of Lumbago, Integumental pain and Musculoskeletal pai
Phase 4
Completed
- Conditions
- Health Condition 1: null- Acute Lumbago, Acute Integumental pain and Acute Musculoskeletal pain
- Registration Number
- CTRI/2010/091/000582
- Lead Sponsor
- Fermenta Biotech Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 120
Inclusion Criteria
1) Patients of either sex between 18 to 60 years of age.
2) Patients suffering from acute conditions of Lumbago, Integumental and Musculoskeletal pain
Exclusion Criteria
1) Any specific condition which does not justify patients inclusion in the study in the opinion of the investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method SafetyTimepoint: Baseline Visit and End of the Treatment
- Secondary Outcome Measures
Name Time Method EfficacyTimepoint: